Search tips
Search criteria 


Logo of annrcseLink to Publisher's site
Ann R Coll Surg Engl. 2009 May; 91(4): 351.
PMCID: PMC2749417

A Case in Point

Together with my wife, we read this article on the cost that might be saved by not performing group and save prior to elective breast cancer surgery. She had just had elective breast cancer surgery.

She was having completion left mastectomy and right mastectomy following previous lumpectomy with sentinel node biopsy (November 2007) and subsequent level 2 left axillary clearance surgery (December 2007) for a grade 3 left breast cancer 1.5 cm with one micrometastasis and one metastasis confirmed in the axilla. ER and PR were both strongly positive, Herceptin negative.

She completed 4 cycles of Epirubicin and 2.5 cycles of 4 scheduled of CMF complicated by Mycobacterium chelonae infection of her Hickmann line causing a severe atypical pneumonia. She was on a 3-month course of clarithromycin following on initial clarithromycin/ciprofloxacin/meripenem/ linezolid by infusion which brought rapid improvement in condition, as species were resistant to all except clarithromycin.

Her tumour had arisen in an area of previous irradiation fields for Hodgkin' lymphoma treated in her early 20s (she had 4 relapses). She had been under follow-up in the local MR breast scanning screening programme started for long-term Hodgkin' survivors but sadly her lesion was not identified and she found the lump herself.

At 6 h postoperatively, she had severe sudden haemorrhage with blood pressure dropping to 60/? and tachycardia of 120 requiring return to theatre. She was transfused with two units of irradiated blood of her own blood group (as previously grouped and saved) and had a further unit of irradiated universal donor blood. She had only recently found out re TA-GvHD from Lymphoma Matters (quarterly newsletter from the Lymphoma Association, Issue 74, Summer 2008) and also having come across the NHS leaflet Information for patients needing irradiated blood. (Blood for Hodgkin' disease patients is irradiated to prevent the life-long risk of graft versus host disease.)

We were grateful for the rapidity of response of her surgical team and the availability of blood, otherwise her outcome may not have been so good. We would disagree with the assertion that money can be saved by not doing group and save for patients for elective breast cancer surgery as potentially losing the life (or having a significant hypotensive complication) of a comparatively young patient for lack of transfused blood would easily involve the clinicians/hospital involved in expensive litigation!

Articles from Annals of The Royal College of Surgeons of England are provided here courtesy of The Royal College of Surgeons of England